1.
In the setting of fertility-sparing endometrial cancer treatment,
which molecular subtype appears to be associate with best response rates to progesterone therapy?
1 out of 3
2.
Focusing on Trastuzumab-deruxtecan (T-DXd) toxiticy,
which is the most concerning adverse event of special interest?
2 out of 3
3.
Did you know that hysteroscopic resection leads to better outcomes
including higher complete response and pregnancy rates, and lower recurrence rates, compared to oral progestins and IUD?
3 out of 3
Register
